The effects of graphene oxide nanosheets localized on F-actin filaments on cell-cycle alterations

Biomaterials

Volumn 34, Issue 5, 2013, Pages 1562-1569

  Matesanz, María Concepción ^a   Vila, Mercedes ^b,c   Feito, María José ^a   Linares, Javier ^a   Gonçalves, Gil ^d   Vallet Regi, María ^b,c   Marques, Paula Alexandrina A P ^d   Portolés, María Teresa ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^d UNIVERSITY OF AVEIRO   (Portugal)

Author keywords

Actin; Biocompatibility; Interleukin; Macrophage; Nanoparticle; Osteoblast

Indexed keywords

ACTIN; BIOMEDICAL APPLICATIONS; CELL CYCLE; CELL MARKERS; CELL RESPONSE; CELL TYPES; ELECTRICAL AND MECHANICAL PROPERTIES; F-ACTIN FILAMENTS; GRAPHENE OXIDES; IN-VITRO; INTERLEUKIN; MC3T3-E1; NANOMATERIAL; PHOTOTHERMAL CANCER THERAPY; PREOSTEOBLASTS; SAOS-2 OSTEOBLASTS; SYNERGISTIC FACTOR;

BIOCOMPATIBILITY; BIOMECHANICS; CELL DEATH; ETHYLENE GLYCOL; MACROPHAGES; MECHANICAL PROPERTIES; MEDICAL APPLICATIONS; NANOPARTICLES; OSTEOBLASTS;

PROTEINS;

F ACTIN; GRAPHENE OXIDE; MACROGOL; NANOMATERIAL; NANOSHEET; POLY(ETHYLENE GLYCOL AMINE); UNCLASSIFIED DRUG;

ACTIN FILAMENT; ANIMAL CELL; APOPTOSIS; ARTICLE; BIOCOMPATIBILITY; CELL CYCLE; HUMAN; HUMAN CELL; MACROPHAGE; NONHUMAN; OSTEOBLAST; OXIDATIVE STRESS; PRIORITY JOURNAL;

ACTIN CYTOSKELETON; ACTINS; CELL CYCLE; CELL CYCLE PROTEINS; GRAPHITE; NANOPARTICLES; OXIDES;

EID: 84870679300     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.11.001     Document Type: Article

References (36)

1. Novoselov K.S., Geim A.K., Morozov S.V., Jiang D., Zhang Y., Dubonos S.V., et al. Electric field effect in atomically thin carbon films. Science 2004, 306:666-669.
2. Sanchez V.C., Jachak A., Hurt R.H., Kane A.B. Biological interactions of graphene-family nanomaterials: an interdisciplinary review. Chem Res Toxicol 2012, 25:15-34.
3. Geim A.K. Graphene: status and prospects. Science 2009, 324:1530-1534.
4. Ruoff R. Graphene: calling all chemists. Nat Nanotechnol 2008, 3:10-11.
5. Sun X., Liu Z., Welsher K., Robinson J.T., Goodwin A., Zaric S., et al. Nano-graphene oxide for cellular imaging and drug delivery. Nano Res 2008, 1:203-212.
6. Zhang L., Xia J., Zhao Q., Liu L., Zhang Z. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small 2010, 6:537-544.
7. Fan H., Wang L., Zhao K., Li N., Shi Z., Ge Z., et al. Fabrication, mechanical properties, and biocompatibility of graphene-reinforced chitosan composites. Biomacromolecules 2010, 11:2345-2351.
8. Depan D., Girase B., Shah J.S., Misra R.D. Structure-process-property relationship of the polar graphene oxide-mediated cellular response and stimulated growth of osteoblasts on hybrid chitosan network structure nanocomposite scaffolds. Acta Biomater 2011, 7:3432-3445.
9. Huang P., Xu C., Lin J., Wang C., Wang X., Zhang C., et al. Folic acid-conjugated graphene oxide loaded with photosensitizers for targeting photodynamic therapy. Theranostics 2011, 1:240-250.
10. Yang K., Zhang S., Zhang G., Sun X., Lee S.T., Liu Z. Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett 2010, 10:3318-3323.
11. Kam N.W., O'Connell M., Wisdom J.A., Dai H. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc Natl Acad Sci U S A 2005, 102:11600-11605.
12. Park S., An J., Jung I., Piner R.D., An S.J., Li X., et al. Colloidal suspensions of highly reduced graphene oxide in a wide variety of organic solvents. Nano Lett 2009, 9:1593-1597.
13. Liu Z., Robinson J.T., Sun X., Dai H. PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J Am Chem Soc 2008, 130:10876-10877.
14. Gollavelli G., Ling Y.C. Multi-functional graphene as an in vitro and in vivo imaging probe. Biomaterials 2012, 33:2532-2545.
15. Wang K., Ruan J., Song H., Zhang J., Wo Y., Guo S., et al. Biocompatibility of graphene oxide. Nanoscale Res Lett 2011, 6:8.
16. Yang K., Wan J., Zhang S., Zhang Y., Lee S.T., Liu Z. In vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice. ACS Nano 2011, 5:516-522.
17. Chang Y., Yang S.T., Liu J.H., Dong E., Wang Y., Cao A., et al. In vitro toxicity evaluation of graphene oxide on A549 cells. Toxicol Lett 2011, 200:201-210.
18. Liu X., Sen S., Liu J., Kulaots I., Geohegan D., Kane A., et al. Antioxidant deactivation on graphenic nanocarbon surfaces. Small 2011, 4(7):2775-2785.
19. Zhang Y., Ali S.F., Dervishi E., Xu Y., Li Z., Casciano D., et al. Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells. ACS Nano 2010, 4:3181-3186.
20. Hu W., Peng C., Lv M., Li X., Zhang Y., Chen N., et al. Protein corona-mediated mitigation of cytotoxicity of graphene oxide. ACS Nano 2011, 5:3693-3700.
21. Vila M., Portolés M.T., Marques P.A.A.P., Feito M.J., Matesanz M.C., Ramírez-Santillán C., et al. Cell uptake survey of pegylated nano graphene oxide. Nanotechnology 2012, 23(465103):9.
22. Gonçalves G., Marques P.A.A.P., Granadeiro C., Nogueira H.I.S., Singh M.K., Grácio J. Surface modification of graphene nanosheets with gold nanoparticles: the role of oxygen moieties at graphene surface on gold nucleation and growth. Chem Mater 2009, 21:4796-4802.
23. Kalvacova M., Broz A., Kong J., Kalbac M. Graphene substrates promote adherence of human osteoblasts and mesenchymal stromal cells. Carbon 2010, 48:4323-4329.
24. Chun Y.W., Wang W., Choi J., Nam T.H., Lee Y.H., Cho K.K., et al. Control of macrophage responses on hydrophobic and hydrophilic carbon nanostructures. Carbon 2011, 49:2092-2103.
25. Nayak T.R., Andersen H., Makam V.S., Khaw C., Bae S., Xu X., et al. Graphene for controlled and accelerated osteogenic differentiation of human mesenchymal stem cells. ACS Nano 2011, 5:4670-4678.
26. Fassina L., Visai L., Asti L., Benazzo F., Speziale P., Tanzi M.C., et al. Calcified matrix production by Saos-2 cells inside a polyurethane porous scaffold, using a perfusion bioreactor. Tissue Eng 2005, 11:685-700.
27. Mayr-Wohlfart U., Fiedler J., Günther K.P., Puhl W., Kessler S. Proliferation and differentiation rates of a human osteoblast-like cell line (Saos-2) in contact with different bone substitute materials. J Biomed Mater Res 2001, 57:132-139.
28. Rodan S.B., Imai Y., Thiede M.A., Wesolowski G., Thompson D., Bar-Shavit Z., et al. Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties. Cancer Res 1987, 15:4961-4966.
29. Raschke W.C., Baird S., Ralph P., Nakoinz I. Functional macrophage cell lines transformed by Abelson leukemia virus. Cell 1978, 15:261-267.
30. Li Y., Liu Y., Fu Y., Wei T., Guyader L.L., Gao G., et al. The triggering of apoptosis in macrophages by pristine graphene through the MAPK and TGF-beta signalling pathways. Biomaterials 2012, 33:402-411.
31. Sun B., Geng S., Huang X., Zhu J., Liu S., Zhang Y., et al. Coleusin factor exerts cytotoxic activity by inducing G0/G1 cell cycle arrest and apoptosis in human gastric cancer BGC-823 cells. Cancer Lett 2011, 301:95-105.
32. Sanchez I., Dynlacht B.D. New insights into cyclins, CDKs, and cell cycle control. Semin Cell Dev Biol 2005, 16:311-321.
33. Shah M.A., Schwartz G.K. Cyclin-dependent kinases as targets for cancer therapy. Cancer Chemother Biol Response Modif 2005, 22:135-162.
34. Fasshauer M., Iwig M., Glaesser D. Synthesis of proto-oncogene proteins and cyclins depends on intact microfilaments. Eur J Cell Biol 1998, 77:188-195.
35. Portugal M., Barak V., Ginsburg I., Kohen R. Interplay among oxidants, antioxidants, and cytokines in skin disorders: present status and future considerations. Biomed Pharmacother 2007, 61:412-422.
36. Nakajima A., Yamada K., Zou L.-B., Yan Y., Mizuno M., Nabeshima T. Interleukin-6 protects PC12 cells from 4-hydroxynonenal-induced cytotoxicity by increasing intracellular glutathione levels. Free Radic Biol Med 2002, 32:1324-1332.